蒽环类药物
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | (2R)-N-[(2S,3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-2-amino-4-methylpentanamide | 23828-86-6 | C33H40N2O11 |
| —— | 9,10-anhydro-N-(trifluoroacetyl)adriamycin 14-valerate | 80242-55-3 | C34H34F3NO12 |
| —— | 3-fluoro-4-((1-methyl-2-nitro-1H-imidazol-5-yl)methoxy)benzyl (5aS,6S,8R,9aS)-8-(((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)-6-methyltetrahydro-2H-pyrano[4,3-f][1,3,5]dioxazepine-1(6H)-carboxylate | 864923-97-7 | C42H41FN4O16 |
| —— | 1H-benzo[d][1,2,3]triazol-1-yl 4-(((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)amino)-4-oxobutanoate | 273216-91-4 | C37H36N4O14 |
| —— | 7,9-Bis-O-(2,3,6-trideoxy-4-O-p-nitrobenzoyl-3-trifluoroacetamido-α-L-lyxo-hexopyranosyl)-ε-rhodomycinone | 132817-52-8 | C52H46F6N4O21 |
| —— | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1-methoxy-8-(4-morpholinylacetyl)-6,8,11-trihydroxy-, (8S-cis)- | 76549-16-1 | C31H36N2O11 |
| —— | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(4-methoxy-1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, hydrochloride | 79898-08-1 | C33H42ClNO11 |
| —— | (8S,10S)-8-(2-Bromo-acetyl)-10-((3aR,4S,6R,7R,7aR)-7-fluoro-2,2,4-trimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yloxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-naphthacene-5,12-dione | 114643-60-6 | C30H30BrFO11 |
| —— | 3'-N-propionyldaunorubicin | 38942-74-4 | C30H33NO11 |
| —— | N,N-Dimethyladriamycin | 70222-95-6 | C29H33NO11 |
| —— | (7S,9S)-7-<(3'-amino-2',3',6'-trideoxy-α-L-lyxohexopyranosyl)oxy>-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-<<<(4-nitrophenyl)carbamoyl>oxy>methyl>-5,12-naphthacenedione hydrochloride | 91684-89-8 | C32H31N3O12*ClH |
| —— | (7S,9S)-9-acetyl-6-amino-7-[(2R,4R,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione | 115281-40-8 | C26H28N2O8 |
| —— | (7S,9S)-7-<(3'-amino-2',3',4',6'-tetradeoxy-α-L-threohexopyranosyl)oxy>-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-<<(phenylcarbamoyl)oxy>methyl>-5,12-naphthacenedione hydrochloride | 91578-20-0 | C32H32N2O9*ClH |
| —— | N-(trifluoroacetyl) doxorubicin 14-O-(3'-amino) propanoate | 135672-71-8 | C32H33F3N2O13 |
| —— | 2'-Hydroxydaunorubicin | 66169-99-1 | C27H29NO11 |
| —— | 14-O-Acetyldoxorubicin | 30489-04-4 | C29H31NO12 |
| —— | N-(5,5-diacetoxy-pent-1-yl)doxorubicin hydrochloride | 142632-21-1 | C36H43NO15*ClH |
| —— | 3'-deamino-3"-4'-anhydro-[2"(S)-ethoxy-3"(R)-hydroxy-4"-morpholinyl] doxorubicin | 1377918-03-0 | C33H37NO13 |
| —— | N-Methyldaunomycin | 67508-86-5 | C28H31NO10 |
| —— | 6-Amino-hexanoic acid {(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxy-acetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy]-tetrahydro-pyran-4-yl}-amide | 182361-15-5 | C33H40N2O12 |
| —— | 4-O-methyl-7-O-<2,3,4,6-tetradeoxy-3,4-bis(trifluoroacetamido)-α-L-lyxo-hexopyranosyl>-β-rhodomycinone | 132065-00-0 | C31H30F6N2O11 |
| —— | 7-O-<2-fluoro-2,3,6-trideoxy-3-(trifluoroacetamido)-α-L-galactopyranosyl>daunomycinone | 99018-21-0 | C29H27F4NO11 |
| —— | 1440533-60-7 | C33H62O8Si3 | |
| —— | 4-Dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid (2-p-tolyl-cyclohept-1-enyl)-amide | 37424-23-0 | C36H40N2O8 |
| —— | 5,12-Naphthacenedione, 8-acetyl-10-((2,6-dideoxy-2-iodo-alpha-L-talopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)- | 152519-39-6 | C27H27IO11 |
| —— | 6,7,11-tri-O-methyl-4-demethoxy-12-sulfonodaunomycinone | 95635-99-7 | C22H22O8S |
| —— | Fmoc-Phe-Lys(MMT)-PABC-Dox | 847871-55-0 | C85H83N5O18 |
| —— | 5-deoxydoxorubicin hydrochloride | 120001-59-4 | C27H29NO10*ClH |
| —— | 1049627-35-1 | C67H76N14O20 | |
| —— | CDMC12-Dox | 847068-23-9 | C47H62N2O15 |
| —— | 7-O-(3,4-diamino-2,3,4,6-tetradeoxy-α-L-lyxo-hexopyranosyl)-4-O-methyl-β-rhodomycinone | 131926-64-2 | C27H32N2O9 |
| —— | Doxo-4'-9,4-trisuccinic ester | 1163726-28-0 | C39H41NO20 |
| —— | 393523-26-7 | C71H78N8O22 | |
| —— | 1608127-19-0 | C44H39NO13 | |
| —— | N-(trifluoroacetyl)-14-O-(N-acetylphenylalanyl)adriamycin | 101980-57-8 | C40H39F3N2O14 |
| —— | 16β-hydroxymethyl-1,3,5(10)-estratrien-3,17-diol-16α-octanoic acid N-doxorubicinamide | 1399156-31-0 | C54H67NO15 |
| —— | 1608127-28-1 | C49H61N3O17 | |
| —— | 3'-deamino-3"-4'-anhydro-[2"(S)-methoxy-3"(R)-hydroxy-4"-morpholinyl] daunorubicin | 1377917-99-1 | C32H35NO12 |
| —— | N-(L-arginine)doxorubicin | 123105-78-2 | C33H41N5O12 |
| —— | Cap3-PLG-S(OBn)YL-Dox; Cap3 = 3-sulfobenzoic acid | 1218936-48-1 | C72H85N7O23S |
| —— | 3'-N-(Nα-Fmoc-D-Val-Leu-Nε-Fmoc-Lys)-Dox | 84624-22-6 | C74H81N5O18 |
| —— | N-(5-acetoxypent-1-yl)doxorubicin | 142632-22-2 | C34H41NO13 |
| —— | 1608127-30-5 | C57H78N2O22 | |
| —— | 14-O-(p-anisyldiphenylmethyl)-N-(trifluoroacetyl)doxorubicin | 77331-70-5 | C49H44F3NO13 |
| —— | Cap3-PQG-S(OBn)YL-Dox; Cap3 = 3-sulfobenzoic acid | 1218936-47-0 | C71H82N8O24S |
| —— | 16β-hydroxymethyl-1,3,5(10)-estratrien-3,17-diol-16α-decanoic acid N-doxorubicinamide | 1399156-34-3 | C56H71NO15 |
| —— | Ac-PLG-Hof-K(NMe2)-L-Dox; Hof = homophenylalanine | 1218936-39-0 | C66H90N8O18 |
| —— | 913196-33-5 | C45H62N12O16 | |
| —— | 3'-deamino-3'-(3-cyano-4-morpholinyl)-13-dihydrodoxorubicin | 89164-77-2 | C32H36N2O12 |
| —— | Doxo-4'-14-bis-succinic ester | 1163726-27-9 | C35H37NO17 |
联系我们
关注我们
公众号
